Skip to main content
Elsevier
View Cart

Esophageal Disease and the Role of the Microbiome

  • 1st Edition - November 23, 2022
  • Latest edition
  • Editor: David A. Johnson
  • Language: English

Esophageal Diseases and the Role of the Microbiome provides evidence on biomic influence in esophageal diseases. The book builds on the translational information on H pylori for ul… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Esophageal Diseases and the Role of the Microbiome provides evidence on biomic influence in esophageal diseases. The book builds on the translational information on H pylori for ulcer disease as well as the explosive focus on biomic influence in virtually all areas of esophageal diseases. This important reference will help translational researchers by providing scientific understanding and hypothesis generation that is needed for furthering this field of study. It will also provide clinicians with disease management options for esophageal diseases (for GERD and PPI options/side effects) and present cutting-edge science to promote provider/patient understanding and options.

Key features

  • Delivers a translational understanding of new paradigms for esophageal disease
  • Explains the effects of microbiome balance in the esophagus
  • Suggests potential treatment options of esophageal dysbiosis

Readership

Both basic science researchers and gastroenterologists, Primary care physicians dealing with GERD/esophageal disease

Table of contents

1. Is acid the cornerstone factor in gastroesophageal reflux disease and its related complications?

2. Cytokines and immune modulators—Effects on esophageal Inflammation

3. Acid suppression and effects on the gastrointestinal microbiome

4. Esophageal dysbiosis and pathogenesis of gastroesophageal reflux disease

5. Gastroesophageal reflux disease and the role of Helicobacter pylori

6. Esophageal dysbiosis and neoplasia: Moving from Barrett's esophagus to adenocarcinoma

7. Esophageal dysbiosis and esophageal squamous cell carcinoma

8. Esophageal dysbiosis and eosinophilic esophagitis—Bacteria to blame?

9. Laryngopharyngeal reflux and dysbiosis

10. Esophageal dysbiosis and esophageal motility disorders

11. Gastrointestinal microbiome: Evaluation of testing technologies

12. Esophagogastric microbiome—Internal and external influences effecting variance

13. Esophageal dysbiosis—Correcting the paradox: Prebiotics, probiotics, or antibiotics?

Product details

  • Edition: 1
  • Latest edition
  • Published: November 23, 2022
  • Language: English

About the editor

DJ

David A. Johnson

Dr. Johnson MD, MACG, FASGE, MACP is Professor of Medicine and Chief of Gastroenterology at Eastern VA School of Medicine. He co-founded the National Medicare Carrier Advisory Committee. He served on the GI Multi-Society CRC Screening Task Force and ACG guidelines committee for CRC screening, and co-authored the national guidelines. He served on the American Board of Internal Medicine (Gastroenterology), Board of Examiners (2012-2017), and was reappointed to the Maintenance of Certification ABIM Board 2020-present. He has been honored with the highest award from the American College of Gastroenterology; the Berk/Fise Award for lifetime achievements, as well as the William D Carey ACG Governors award to lifetime contributions to gastroenterology. He is the physician who worked with Virginia State Senator Emily Couric to put through the historic legislation to mandate colon cancer screening with colonoscopy as the preferred standard. This initiative has set the model for other states which have followed with similar legislation.
Affiliations and expertise
Professor of Medicine and Chief of Gastroenterology, Eastern Virgina Medical School, Norfolk, VA, United States

View book on ScienceDirect

Read Esophageal Disease and the Role of the Microbiome on ScienceDirect